Pfizer Inc. subsidiary Greenstone LLC recalled one lot of its Citalopram depression medicine and its prostate drug Finasteride because the wrong labels may have been put on the bottles, said the U.S. Food and Drug Administration.
Greenstone said in a recall notice that bottles of Citalopram, a generic drug with trade names including Celexa, may contain Finasteride, used to treat prostate problems and baldness in men. Finasteride's trade names include Proscar, Propecia and several others.
Consumers who took the wrong medication should immediately contact their doctors. Women who are pregnant or may become pregnant shouldn't touch Finasteride, classified pregnancy category X because it can be absorbed through the skin and harm fetuses.
Further, consumers who suddenly stop taking the antidepressant Citalopram could experience worse depression and withdrawal symptoms.Greenstone said that its third-party manufacturer could have put the wrong labels on the drugs.
Included in the recall are Citalopram 10mg tablets in a 100-pill bottle and Finasteride 5mg tablets in a 90-count bottle. Both have the lot number FI050058-A on the label.
Consumers should return any medicine with those numbers to their pharmacist and contact their doctors if they feel any effects from taking the recalled medicine.
Last year Pfizer recalled several lots of its cholesterol drug Lipitor after consumers complained about a musty, foul odor from the bottles. A similar circumstance prompted a massive recall of Tylenol.
Investing in Emerging Markets
Learn to invest in a globalized world.View Course »